|
RPTX Repare Therapeutics Inc 1808158 |
| Balance Sheet |
|
Current Assets
|
200,403,000 |
|
Assets
|
206,389,000 |
|
Current Liabilities
|
31,084,000 |
|
Liabilities
|
31,430,000 |
|
Equity
|
174,959,000 |
|
Shares Out
|
42,446,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-49,121,000 |
|
Investing Cash Flow
|
17,882,000 |
| Market Analysis |
Market Cap
|
138,372,394 |
|
Price
|
1.28 |
|
BVPS
|
4.12 |
|
PB
|
0.31 |
|
EPS
|
-1.63 |
|
PS
|
18.36 |
|
FCF
|
-31,239,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RPTX documents filed with the SEC.
RPTX Filings
Clear
